Mayo Clinic Ventures commercializes technologies to benefit patients while generating revenue to support clinical practice, research and education. Thanks in part to licensing and partnership efforts, 2018 was a banner year for Mayo Clinic Ventures' financial performance.
Mayo Clinic has a long and storied history of firsts — the first nonprofit practice aligned with research and education, the discovery of cortisone, the first hip replacement approved by the Food and Drug Administration. The list goes on. When patients need answers, Mayo staff aim to find solutions.
Many of these innovations often have far-reaching effects, changing the delivery of health care on a much larger scale. When it comes to translating discoveries into products that help patients, that's where Mayo Clinic Ventures comes in.
Mayo Clinic Ventures commercializes Mayo Clinic discoveries to benefit patients around the world while generating revenue to support clinical practice, research and education.
"We take the innovation and discoveries from the Research, Education and Practice shields, and help translate them into products that can help patients," says Andrew Danielsen, chair of Mayo Clinic Ventures. Danielsen leads a diverse team of skilled professionals working with Mayo Clinic staff to advance medical care. Read the rest of the article on Advancing the Science blog.
Other Mayo Clinic medical research websites: